Advertisement

Taurine 3 pp 85-89 | Cite as

Effect of Taurine on Biliary Metabolites of Glutathione in Liver Perfused with the Pyrrolizidine Alkaloid, Monocrotaline

  • Chong Chao Yan
  • Ryan J. Huxtable
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 442)

Abstract

Pyrrolizidines are a group of hepatotoxic plant alkaloids6,9. Certain pyrrolizidines are also toxic to lung, heart, the central nerve system, and other organs. Hepatic bioactivation is required for the expression of toxicity8.

Keywords

Perfuse Liver Pyrrolizidine Alkaloid Taurine Concentration Taurine Administration Biliary Metabolite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abbott, W.A. and Meister, A., 1986, Intrahepatic transport and utilization of biliary glutathione and its metabolites, Proc. Natl. Acad. Sci., 83:1246–1250.PubMedCrossRefGoogle Scholar
  2. 2.
    Ballatori, N. and Clarkson, R.W., 1985, Biliary secretion of glutathione and of glutathione-metal complexes, Fund. Appl. Toxicol., 5:816–831.CrossRefGoogle Scholar
  3. 3.
    Ballatori, N., Jacob, R., and Boyer, J.L., 1986, Intrabiliary glutathione hydrolysis — a source of glutamate in bile, J. Biol. Chem., 261:7860–7865.PubMedGoogle Scholar
  4. 4.
    Cooper, R.A. and Huxtable, R.J., 1996, A simple procedure for determining the aqueous half-lives of pyrrolic metabolites of pyrrolizidine alkaloids, Toxicon, 34:604–607.PubMedCrossRefGoogle Scholar
  5. 5.
    Glowaz, S.L., Michnika, M., and Huxtable, R.J., 1992, Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline, Toxicol. Appl. Pharmacol., 115:168–173.PubMedCrossRefGoogle Scholar
  6. 6.
    Huxtable, R.J., 1989, Human health implications of pyrrolizidine alkaloids and herbs containing them, in: “Toxicants of Plant Origin, Vol I: Alkaloids”,. Cheeke, P.R., ed., CRC Press, Boca Raton, Florida, pp. 41–86.Google Scholar
  7. 7.
    Huxtable, R.J., 1996, Taurine: Past, present and future, in: “Taurine: Basic and Clinical Aspects”,. Huxtable, R.J., Azuma, J., Nakagawa, M, Kuriyama, K., and Baba, A., eds., Plenum, New York. pp. 641–650.Google Scholar
  8. 8.
    Mattocks, A.R., 1968, Toxicity of pyrrolizidine alkaloids, Nature (London), 217:723–728.CrossRefGoogle Scholar
  9. 9.
    Mattocks, A.R., 1986, Chemistry and Toxicology of Pyrrolizidine Alkaloids. Academic Press, London.Google Scholar
  10. 10.
    Nakashima, T., Takino, T., and Kuriyama, K., 1982, Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury, Jpn. J. Pharmacol, 32:583–590.PubMedCrossRefGoogle Scholar
  11. 11.
    Waterfield, C.J., Turton, J.A., Scales, M.D.C., and Timbrell, J.A., 1991, Taurine, a possible urinary marker of liver damage: A study of taurine excretion in carbon tetrachloride-treated rats, Arch. Toxicol., 65:548–555.PubMedCrossRefGoogle Scholar
  12. 12.
    Yan, C.C., Cooper, R.A., and Huxtable, R.J., 1995, The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver, Toxicol. Appl. Pharmacol., 133:277–284.PubMedCrossRefGoogle Scholar
  13. 13.
    Yan, C.C. and Huxtable, R.J., 1994, Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline, Toxicoi Appl. Pharmacol., 127:58–63.CrossRefGoogle Scholar
  14. 14.
    Yan, C.C. and Huxtable, R.J., 1995a, Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver, Life Sci., 57:617–626.PubMedCrossRefGoogle Scholar
  15. 15.
    Yan, C.C. and Huxtable, R.J., 1995b, Fluorimetric determination of monobromobimane and ophthalaldehyde adducts of gamma-glutamylcysteine and glutathione: Application to assay of gamma — glutamylcysteinyl synthetase activity and glutathione concentration in liver, J. Chromatogr. B Biomed. Appl., 672:217–224.PubMedCrossRefGoogle Scholar
  16. 16.
    Yan, C.C. and Huxtable, R.J., 1995c, Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver, Toxicol. Appl. Pharmacol., 130:132–139.PubMedCrossRefGoogle Scholar
  17. 17.
    Yan, C.C. and Huxtable, R.J., 1996, Effects of taurine and guanidinoethane sulfonate on right ventricular hypertrophy induced by the pyrrolizidine alkaloid, monocrotaline, Biochem. Pharmacol., 51:321–329.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Chong Chao Yan
    • 1
  • Ryan J. Huxtable
    • 1
  1. 1.Department of PharmacologyUniversity of Arizona, College of MedicineTucsonUSA

Personalised recommendations